MIB-1 and p53 expression in radiotherapy-resistant TlaN0M0 glottic squamous cell carcinoma

Clinical Otolaryngology and Allied Sciences

Volumn 26, Issue 3, 2001, Pages 227-230

  Motamed, M ^a,c   Banerjee, A R ^a   Bradley, P J ^b   Powe, D ^b  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

^c DERBYSHIRE ROYAL INFIRMARY   (United Kingdom)

Author keywords

Immunohistochemistry; Laryngeal; Mib 1; Neoplasm; p53; Radiation resistance

Indexed keywords

BIOLOGICAL MARKER; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY KI 67; PROTEIN P53;

ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CONTROLLED STUDY; GLOTTIS; HEAD AND NECK TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTIGENS, NUCLEAR; CARCINOMA, SQUAMOUS CELL; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LARYNGEAL NEOPLASMS; MUTATION; NUCLEAR PROTEINS; PROGNOSIS; RADIATION TOLERANCE; TREATMENT FAILURE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035725475     PISSN: 03077772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2273.2001.00461.x     Document Type: Article

References (32)

1. Management of early glottic cancer
2. Is p53 an independent prognostic factor in patients with laryngeal carcinoma?
3. Markers of radioresistance in squamous cell carcinomas of the head and neck: A clinicopathologic and immmunhistochemical study
4. p53 expression in end stage squamous cell carcinoma of the head and neck prior to chemotherapy treatment: Expression correlates with a very poor clinical outcome
5. Has the cellular proliferation marker Ki-67 any clincal relevance in squamous cell carcinoma of the head and neck?
6. Overexpression of p53 in head and neck cancer
7. Tumour proliferation, p53 expression, and apoptosis in laryngeal carcinoma: Relation to the results of radiotherapy
8. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma
9. Demystified: p53
10. p53 overexpression is an early event in the development of human squamous cell carcinoma of the larynx: Genetic and prognostic implications
11. High frequency of p53 gene alteration associated with protein overexpression in human squamous cell carcinoma of the larynx
12. Assessment of p53 protein expression in normal, benign, and malignant oral mucosa
13. Production of a monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation
14. Monoclonal antibody Ki-67: Its use in histopathology
15. Direct comparison of bromodeoxyuridine and Ki-67 labelling indices in human tumours
16. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope
17. Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumour front grading, and proliferation markers
18. Ki-67 and p53 in T2 laryngeal cancer
19. p53 overexpression corrrelates with proliferative activity and prognosis in carcinomas of the pyriform sinus
20. Ki-67 immunostaining and prognosis in laryngeal cancer
21. Participation of p53 protein in the cellular response to DNA damage
22. Letter to the editors
23. p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines
24. p53 overexpression in head and neck carcinoma and radiotherapy results
25. The role of p53 tumour suppressor gene in squamous cell carcinoma of the head and neck
26. p53 over-expression in laryngeal carcnimoa is not predictive of response to radiotherapy
27. p53 in tumour pathology: Can we trust immunohistochemistry? Revisited!
28. p53 mutations in human cancers
29. p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck
30. Cell proliferation assessment in oncology
31. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck
32. Radiation response of tumours: Experimental